Remy Sukhija

Remy Sukhija

Former Senior Vice President, Chief Commercial OfficeratMadrigal Pharmaceuticals· In proxies 2021–2023

Pay in FY2023+110% from the year before · Madrigal Pharmaceuticals stock -20.3% the same year

Remy Sukhija was paid $7.4M in FY2023 (Dec), up 110%. Madrigal Pharmaceuticals stock fell 20.3% that year.

Pay$100 in the stock at the end of FY20 → $208
Pay is from the Summary Compensation Table of each Madrigal Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Madrigal PharmaceuticalsPublic company · 5 yr
    • Former Senior Vice President, Chief Commercial Officer2021 – Present · 5 yrStock in role +259%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?